131 related articles for article (PubMed ID: 32795678)
21. ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM COMPARED WITH FINDINGS IN HYPERCALCEMIC PRIMARY HYPERPARATHYROID PATIENTS AND CONTROL SUBJECTS.
Pepe J; Colangelo L; Sonato C; Occhiuto M; Ferrara C; Del Fattore A; Santori R; Mastrantonio M; Sgreccia A; Minisola S; Cipriani C
Endocr Pract; 2021 Jan; 27(1):21-26. PubMed ID: 33475498
[TBL] [Abstract][Full Text] [Related]
22. Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis.
Victor F; Pereira Lemos AL; de Holanda Ribas AM; Bandeira L; Pimentel JH; de Andrade Damázio LO; Bandeira F
Int J Endocrinol; 2022; 2022():4558236. PubMed ID: 35437440
[TBL] [Abstract][Full Text] [Related]
23. [Special features of the diagnostics and treatment of hereditary primary hyperparathyroidism].
Mogl MT; Goretzki PE
Chirurgie (Heidelb); 2023 Jul; 94(7):586-594. PubMed ID: 37291366
[TBL] [Abstract][Full Text] [Related]
24. Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone?
Amaral LM; Queiroz DC; Marques TF; Mendes M; Bandeira F
J Osteoporos; 2012; 2012():128352. PubMed ID: 22545220
[TBL] [Abstract][Full Text] [Related]
25. Effect of Physical Activity versus Health Education on Physical Function, Grip Strength and Mobility.
Santanasto AJ; Glynn NW; Lovato LC; Blair SN; Fielding RA; Gill TM; Guralnik JM; Hsu FC; King AC; Strotmeyer ES; Manini TM; Marsh AP; McDermott MM; Goodpaster BH; Pahor M; Newman AB;
J Am Geriatr Soc; 2017 Jul; 65(7):1427-1433. PubMed ID: 28221668
[TBL] [Abstract][Full Text] [Related]
26. Body Composition, Serum Sclerostin and Physical Function After Bariatric Surgery: Performance of Dual-Energy X-ray Absorptiometry and Multifrequency Bioelectrical Impedance Analysis.
de Oliveira PAP; Montenegro ACP; Bezerra LRA; da Conceição Chaves de Lemos M; Bandeira F
Obes Surg; 2020 Aug; 30(8):2957-2962. PubMed ID: 32335866
[TBL] [Abstract][Full Text] [Related]
27. The Ca∗Cl/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism.
Yu Y; Qiu J; Chuan F; Feng Z; Long J; Zhou B
Endocr Pract; 2024 Mar; 30(3):231-238. PubMed ID: 38086525
[TBL] [Abstract][Full Text] [Related]
28. Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy.
Vignali E; Cetani F; Chiavistelli S; Meola A; Saponaro F; Centoni R; Cianferotti L; Marcocci C
Endocr Connect; 2015 Sep; 4(3):172-8. PubMed ID: 26155986
[TBL] [Abstract][Full Text] [Related]
29. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
Maruani G; Hertig A; Paillard M; Houillier P
J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
[TBL] [Abstract][Full Text] [Related]
30. Interobserver Reliability of Peripheral Muscle Strength Tests and Short Physical Performance Battery in Patients With Chronic Obstructive Pulmonary Disease: A Prospective Observational Study.
Medina-Mirapeix F; Bernabeu-Mora R; Llamazares-Herrán E; Sánchez-Martínez MP; García-Vidal JA; Escolar-Reina P
Arch Phys Med Rehabil; 2016 Nov; 97(11):2002-2005. PubMed ID: 27255806
[TBL] [Abstract][Full Text] [Related]
31. Correlation of sarcopenia and depressive mood in older community dwellers: a cross-sectional observational study in China.
Chen L; Sheng Y; Qi H; Tang T; Yu J; Lv S
BMJ Open; 2020 Sep; 10(9):e038089. PubMed ID: 32873679
[TBL] [Abstract][Full Text] [Related]
32. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.
Gómez-Ramírez J; Mihai R
Langenbecks Arch Surg; 2017 Nov; 402(7):1103-1108. PubMed ID: 28823005
[TBL] [Abstract][Full Text] [Related]
33. Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes: A pilot study.
Karras SN; Koufakis T; Tsekmekidou X; Antonopoulou V; Zebekakis P; Kotsa K
Diabetes Res Clin Pract; 2020 Feb; 160():107985. PubMed ID: 31866526
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and inter-rater reliability of physical performance measures in acutely admitted older medical patients.
Bodilsen AC; Juul-Larsen HG; Petersen J; Beyer N; Andersen O; Bandholm T
PLoS One; 2015; 10(2):e0118248. PubMed ID: 25706553
[TBL] [Abstract][Full Text] [Related]
35. [Normocalcemic primary hyperparathyroidism].
Spivacow FR; Sapag Durán A; Zanchetta MB
Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
[TBL] [Abstract][Full Text] [Related]
36. Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls.
Winters-Stone KM; Medysky ME; Savin MA
J Geriatr Oncol; 2019 Mar; 10(2):311-316. PubMed ID: 30344000
[TBL] [Abstract][Full Text] [Related]
37. Normocalcemic primary hyperparathyroidism: an update.
Salcuni AS; Battista C; Pugliese F; Columbu C; Guarnieri V; Carnevale V; Scillitani A
Minerva Endocrinol (Torino); 2021 Sep; 46(3):262-271. PubMed ID: 33103871
[TBL] [Abstract][Full Text] [Related]
38. PRIMARY HYPERPARATHYROIDISM, WITH A FOCUS ON MANAGEMENT OF THE NORMOCALCEMIC FORM: TO TREAT OR NOT TO TREAT?
Šiprová H; Fryšák Z; Souček M
Endocr Pract; 2016 Mar; 22(3):294-301. PubMed ID: 26523628
[TBL] [Abstract][Full Text] [Related]
39. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
40. Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form?
Gómez-Ramírez J; Gómez-Valdazo A; Luengo P; Porrero B; Osorio I; Rivas S
Am J Surg; 2020 Jan; 219(1):150-153. PubMed ID: 31662196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
